AAREYDRUGSPharmaceuticals
Aarey Drugs & Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹50.75
-9.78%
Current P/E68.56xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E31.6x117.0% above avg
⚠️
115.8% Premium to Industry
AAREYDRUGS P/E 68.56x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹1.43 | ₹68 | 47.3x |
| 2024 | ₹1.84 | ₹57 | 31x |
| 2023 | ₹1.49 | ₹51 | 33.9x |
| 2022 | ₹2.72 | ₹39 | 14.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Aarey Drugs & Pharmaceuticals Ltd Valuation
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) currently trades at 68.56x earnings. The Pharmaceuticals sector average PE is 31.77x. AAREYDRUGS commands a premium, reflecting high growth expectations. Historically, AAREYDRUGS has traded at an average PE of 31.6x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
2.96%
Dividend Yield
0.00%
More on Aarey Drugs & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.